X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with WYETH LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs WYETH LTD - Comparison Results

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES WYETH LTD ALKEM LABORATORIES/
WYETH LTD
 
P/E (TTM) x - 27.7 - View Chart
P/BV x 6.0 5.3 111.8% View Chart
Dividend Yield % 0.7 1.3 56.9%  

Financials

 ALKEM LABORATORIES   WYETH LTD
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
WYETH LTD
Mar-13
ALKEM LABORATORIES/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs1,5891,044 152.1%   
Low Rs1,232818 150.6%   
Sales per share (Unadj.) Rs417.5298.6 139.8%  
Earnings per share (Unadj.) Rs56.357.2 98.3%  
Cash flow per share (Unadj.) Rs64.758.4 110.8%  
Dividends per share (Unadj.) Rs12.7017.00 74.7%  
Dividend yield (eoy) %0.91.8 49.3%  
Book value per share (Unadj.) Rs292.9249.5 117.4%  
Shares outstanding (eoy) m119.5722.72 526.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.43.1 108.3%   
Avg P/E ratio x25.116.3 154.0%  
P/CF ratio (eoy) x21.815.9 136.7%  
Price / Book Value ratio x4.83.7 129.0%  
Dividend payout %22.629.7 76.0%   
Avg Mkt Cap Rs m168,65321,157 797.2%   
No. of employees `000NA0.5 0.0%   
Total wages/salary Rs m9,171400 2,292.8%   
Avg. sales/employee Rs ThNM13,787.4-  
Avg. wages/employee Rs ThNM813.0-  
Avg. net profit/employee Rs ThNM2,643.3-  
INCOME DATA
Net Sales Rs m49,9156,783 735.8%  
Other income Rs m1,645353 466.6%   
Total revenues Rs m51,5617,136 722.5%   
Gross profit Rs m8,4821,617 524.5%  
Depreciation Rs m1,00627 3,781.2%   
Interest Rs m6716 12,192.7%   
Profit before tax Rs m8,4511,938 436.1%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m1,606632 254.0%   
Profit after tax Rs m6,7311,301 517.6%  
Gross profit margin %17.023.8 71.3%  
Effective tax rate %19.032.6 58.2%   
Net profit margin %13.519.2 70.3%  
BALANCE SHEET DATA
Current assets Rs m27,0626,984 387.5%   
Current liabilities Rs m15,3242,056 745.3%   
Net working cap to sales %23.572.6 32.4%  
Current ratio x1.83.4 52.0%  
Inventory Days Days6799 67.0%  
Debtors Days Days4124 172.4%  
Net fixed assets Rs m12,610244 5,161.5%   
Share capital Rs m239227 105.2%   
"Free" reserves Rs m34,4905,441 633.9%   
Net worth Rs m35,0275,668 618.0%   
Long term debt Rs m1,21225 4,846.4%   
Total assets Rs m54,3877,901 688.4%  
Interest coverage x13.6353.3 3.8%   
Debt to equity ratio x00 784.2%  
Sales to assets ratio x0.90.9 106.9%   
Return on assets %13.616.5 82.3%  
Return on equity %19.222.9 83.8%  
Return on capital %24.934.0 73.0%  
Exports to sales %12.90.2 5,932.8%   
Imports to sales %3.136.3 8.5%   
Exports (fob) Rs m6,46115 43,656.1%   
Imports (cif) Rs m1,5402,465 62.5%   
Fx inflow Rs m6,56315 43,179.6%   
Fx outflow Rs m3,0122,677 112.5%   
Net fx Rs m3,552-2,662 -133.4%   
CASH FLOW
From Operations Rs m7,259923 786.2%  
From Investments Rs m1,864317 588.3%  
From Financial Activity Rs m-9,273-481 1,927.8%  
Net Cashflow Rs m-150759 -19.8%  

Share Holding

Indian Promoters % 66.9 0.0 -  
Foreign collaborators % 0.0 51.1 -  
Indian inst/Mut Fund % 33.1 11.3 292.9%  
FIIs % 0.0 7.2 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 30.4 -  
Shareholders   68,381 21,978 311.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   J.B.CHEMICALS  SUVEN LIFE  STERLING BIOTECH  CADILA HEALTHCARE  VENUS REMEDIES  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Recovery of Global Markets, Apex Frozen Food IPO & Cues to Watch Out Today(Pre-Open)

Indian stock markets remained range-bound in lacklustre trade on Tuesday as market participants kept to the sidelines in the absence of clear triggers.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Aug 22, 2017 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - PFIZER COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS